Stocks & Investing
Mon, September 16, 2024
[ Mon, Sep 16th 2024
] - WOPRAI
Mon, September 9, 2024
[ Mon, Sep 09th 2024
] - WOPRAI
[ Mon, Sep 09th 2024
] - WOPRAI
Wed, September 4, 2024
[ Wed, Sep 04th 2024
] - WOPRAI
Fri, August 16, 2024
[ Fri, Aug 16th 2024
] - WOPRAI
Mon, August 12, 2024
Wed, July 31, 2024
Wed, May 29, 2024
Wed, May 15, 2024
[ Wed, May 15th 2024
] - WOPRAI
Fri, May 3, 2024
[ Fri, May 03rd 2024
] - WOPRAI
Thu, April 18, 2024
[ Thu, Apr 18th 2024
] - WOPRAI
Fri, April 12, 2024
Tue, April 9, 2024
Mon, April 1, 2024
[ Mon, Apr 01st 2024
] - WOPRAI
Tue, February 6, 2024
[ Tue, Feb 06th 2024
] - WOPRAI
Wed, December 20, 2023
[ Wed, Dec 20th 2023
] - WOPRAI
Wed, November 22, 2023
[ Wed, Nov 22nd 2023
] - WOPRAI
Wed, November 8, 2023
[ Wed, Nov 08th 2023
] - WOPRAI
Wed, October 4, 2023
[ Wed, Oct 04th 2023
] - WOPRAI
Mon, September 25, 2023
[ Mon, Sep 25th 2023
] - WOPRAI
Fri, September 15, 2023
[ Fri, Sep 15th 2023
] - WOPRAI
Tue, September 12, 2023
[ Tue, Sep 12th 2023
] - WOPRAI
[ Tue, Sep 12th 2023
] - WOPRAI
Thu, September 7, 2023
[ Thu, Sep 07th 2023
] - WOPRAI
[ Thu, Sep 07th 2023
] - WOPRAI
Li Watsek Reiterated (ASND) at Buy and Held Target at $170 on, Sep 16th, 2024
Li Watsek of Cantor Fitzgerald, Reiterated "Ascendis Pharma A/S" (ASND) at Buy and Held Target at $170 on, Sep 16th, 2024.
Li has made no other calls on ASND in the last 4 months.
There are 10 other peers that have a rating on ASND. Out of the 10 peers that are also analyzing ASND, 1 agrees with Li's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Vikram Purohit of "Morgan Stanley" Maintained at Hold with Increased Target to $140 on, Thursday, May 16th, 2024
These are the ratings of the 9 analyists that currently disagree with Li
- Leland Gershell of "Oppenheimer" Upgraded from Hold to Buy and Held Target at $180 on, Thursday, September 5th, 2024
- Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy with Increased Target to $175 on, Wednesday, September 4th, 2024
- David Lebowitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $178 on, Wednesday, September 4th, 2024
- Derek Archila of "Wells Fargo" Maintained at Buy with Decreased Target to $264 on, Wednesday, September 4th, 2024
- Jessica Fye of "JP Morgan" Maintained at Buy with Decreased Target to $165 on, Wednesday, September 4th, 2024
- Yaron Werber of "TD Cowen" Maintained at Strong Buy with Decreased Target to $157 on, Wednesday, September 4th, 2024
- Kelly Shi of "Jefferies" Maintained at Strong Buy with Increased Target to $196 on, Tuesday, August 13th, 2024
- Paul Choi of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $195 on, Tuesday, August 13th, 2024
- Alex Thompson of "Stifel" Initiated at Strong Buy and Held Target at $200 on, Friday, May 31st, 2024
